Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by pennyDoctoron Oct 07, 2013 10:32pm
145 Views
Post# 21798238

Patent is not Fluorination process

Patent is not Fluorination processThe science of Fluorination is not new. What is new and patentable is adapting the process to known carbohydrate molecules for improved pharmaceutical applicaitons. Sirona's web site mentions that their fluorination process is proprietary, I think they claim this because TFC Chem is owned by Sirona and it is a process used by TFC but not patented by TFC... Sirona needs to get as many novel carbohydrates fluorinated to patent for themselves. The first to market and future source of license money depends on quick research. Fluorinated Arbutin is patented by Sirona there for any one cosmetic company currently using Alpha or Beta Arbutin (TFC849 743 Fluorinated Alpha and Beta) wishing to modify their compound to include Fluorinate Alpha Arbutin will have to sublicense from Obagi. Obagi controls the worlds best skin lightener and could command a high price for it and any sublicenses. Another Unknown company to license the lesser performer Fluorinated Beta Arbutin which is still highly effective and does not produce hydroquinone could run head to head with Obagi's products. This is where multiple licenses could come in to play. $$$$$ Billions... Both lighten the skin and both are safe.
Further to comment made about what If Obagi Fluorinated their own compounds it is simple Sirona would not be the beneficiary. If I am wrong here I am sure there will be some one to correct me. for organic fluorination information go to wikipedia https://en.wikipedia.org/wiki/Organofluorine_chemistry
Still worth a pile more than it is trading at. IMHO
Bullboard Posts